NRX Pharmaceuticals, Inc. (NRXP)
3.76
-0.11
(-2.84%)
USD |
NASDAQ |
Jun 10, 16:00
3.75
-0.01
(-0.27%)
After-Hours: 20:00
NRX Pharmaceuticals SG&A Expense (Quarterly) : 3.813M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.813M |
| December 31, 2025 | 4.569M |
| September 30, 2025 | 2.808M |
| June 30, 2025 | 2.743M |
| March 31, 2025 | 2.943M |
| December 31, 2024 | 2.598M |
| September 30, 2024 | 2.411M |
| June 30, 2024 | 4.246M |
| March 31, 2024 | 4.25M |
| December 31, 2023 | 1.872M |
| September 30, 2023 | 2.494M |
| June 30, 2023 | 4.065M |
| March 31, 2023 | 5.785M |
| December 31, 2022 | 5.432M |
| September 30, 2022 | 5.012M |
| June 30, 2022 | 6.642M |
| March 31, 2022 | 10.22M |
| December 31, 2021 | 46.56M |
| Date | Value |
|---|---|
| September 30, 2021 | 13.82M |
| June 30, 2021 | 4.659M |
| March 31, 2021 | 2.101M |
| December 31, 2020 | 6.541M |
| September 30, 2020 | 3.754M |
| June 30, 2020 | 0.5257M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 1.006M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alto Neuroscience, Inc. | 6.844M |
| LENZ Therapeutics, Inc. | 44.96M |
| LB Pharmaceuticals, Inc. | 7.459M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |